FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2807687788> ?p ?o ?g. }

• W2807687788 endingPage "4031" @default.
• W2807687788 startingPage "4023" @default.
• W2807687788 abstract "Vaccination can significantly reduce worldwide morbidity and mortality to infectious diseases, thereby reducing the health burden as a result of microbial infections. Effective vaccines contain three components: a delivery system, an antigenic component of the pathogen, and an adjuvant. With the growing use of purely recombinant or synthetic antigens, there is a need to develop novel adjuvants that enhance the protective efficacy of a vaccine against infection. Using a structure–activity relationship (SAR) model, we describe here the synthesis of a novel TLR4 ligand adjuvant compound, BECC438, by bacterial enzymatic combinatorial chemistry (BECC). This compound was identified using an in vitro screening pipeline consisting of (i) NFκB activation and cytokine production by immortalized cell lines, (ii) cytokine production by primary human PBMCs, and (iii) upregulation of surface costimulatory markers by primary human monocyte-derived dendritic cells. Using this SAR screening regimen, BECC438 was shown to produce an innate immune activation profile comparable to the well-characterized TLR4 agonist adjuvant compound, phosphorylated hexa-acyl disaccharide (PHAD). To evaluate the in vivo adjuvant activity of BECC438, we used the known protective Yersinia pestis (Yp) antigen, rF1-V, in a murine prime-boost vaccination schedule followed by lethal challenge. In addition to providing protection from lethal challenge, BECC438 stimulated production of higher levels of rF1-V-specific total IgG as compared to PHAD after both prime and boost vaccinations. Similar to PHAD, BECC438 elicited a balanced IgG1/IgG2c response, indicative of active TH2/TH1-driven immunity. These data demonstrate that the novel BECC-derived TLR4L adjuvant, BECC438, elicits cytokine profiles in vitro similar to PHAD, induces high antigen-specific immune titers and a TH1-associated IgG2c immune titer skew, and protects mice against a lethal Yp challenge." @default.
• W2807687788 created "2018-06-13" @default.
• W2807687788 creator A5009579808 @default.
• W2807687788 creator A5034298867 @default.
• W2807687788 creator A5036292296 @default.
• W2807687788 creator A5043813423 @default.
• W2807687788 creator A5044396416 @default.
• W2807687788 creator A5053583356 @default.
• W2807687788 creator A5058752446 @default.
• W2807687788 creator A5067441288 @default.
• W2807687788 creator A5071697192 @default.
• W2807687788 date "2018-06-01" @default.
• W2807687788 modified "2023-10-15" @default.
• W2807687788 title "A lipid A-based TLR4 mimetic effectively adjuvants a Yersinia pestis rF-V1 subunit vaccine in a murine challenge model" @default.
• W2807687788 cites W1519600901 @default.
• W2807687788 cites W1586644347 @default.
• W2807687788 cites W1975300031 @default.
• W2807687788 cites W1982895831 @default.
• W2807687788 cites W1986169276 @default.
• W2807687788 cites W1986260499 @default.
• W2807687788 cites W1989601820 @default.
• W2807687788 cites W1990702493 @default.
• W2807687788 cites W2012905728 @default.
• W2807687788 cites W2019108228 @default.
• W2807687788 cites W2029373703 @default.
• W2807687788 cites W2034829165 @default.
• W2807687788 cites W2046227933 @default.
• W2807687788 cites W2050741855 @default.
• W2807687788 cites W2056489903 @default.
• W2807687788 cites W2091459248 @default.
• W2807687788 cites W2096729904 @default.
• W2807687788 cites W2112291443 @default.
• W2807687788 cites W2122258958 @default.
• W2807687788 cites W2128897591 @default.
• W2807687788 cites W2132032241 @default.
• W2807687788 cites W2143178654 @default.
• W2807687788 cites W2159866361 @default.
• W2807687788 cites W2173327884 @default.
• W2807687788 cites W2256756668 @default.
• W2807687788 cites W226379866 @default.
• W2807687788 cites W2279532173 @default.
• W2807687788 cites W2482786872 @default.
• W2807687788 cites W2570988623 @default.
• W2807687788 cites W2576519196 @default.
• W2807687788 cites W2612082723 @default.
• W2807687788 cites W2614986146 @default.
• W2807687788 cites W2915616832 @default.
• W2807687788 doi "https://doi.org/10.1016/j.vaccine.2018.05.101" @default.
• W2807687788 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6057149" @default.
• W2807687788 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29861179" @default.
• W2807687788 hasPublicationYear "2018" @default.
• W2807687788 type Work @default.
• W2807687788 sameAs 2807687788 @default.
• W2807687788 citedByCount "22" @default.
• W2807687788 countsByYear W28076877882019 @default.
• W2807687788 countsByYear W28076877882020 @default.
• W2807687788 countsByYear W28076877882021 @default.
• W2807687788 countsByYear W28076877882022 @default.
• W2807687788 countsByYear W28076877882023 @default.
• W2807687788 crossrefType "journal-article" @default.
• W2807687788 hasAuthorship W2807687788A5009579808 @default.
• W2807687788 hasAuthorship W2807687788A5034298867 @default.
• W2807687788 hasAuthorship W2807687788A5036292296 @default.
• W2807687788 hasAuthorship W2807687788A5043813423 @default.
• W2807687788 hasAuthorship W2807687788A5044396416 @default.
• W2807687788 hasAuthorship W2807687788A5053583356 @default.
• W2807687788 hasAuthorship W2807687788A5058752446 @default.
• W2807687788 hasAuthorship W2807687788A5067441288 @default.
• W2807687788 hasAuthorship W2807687788A5071697192 @default.
• W2807687788 hasBestOaLocation W28076877882 @default.
• W2807687788 hasConcept C104317684 @default.
• W2807687788 hasConcept C147483822 @default.
• W2807687788 hasConcept C203014093 @default.
• W2807687788 hasConcept C22070199 @default.
• W2807687788 hasConcept C2777863537 @default.
• W2807687788 hasConcept C2778222588 @default.
• W2807687788 hasConcept C55493867 @default.
• W2807687788 hasConcept C60987743 @default.
• W2807687788 hasConcept C86803240 @default.
• W2807687788 hasConcept C8891405 @default.
• W2807687788 hasConcept C89423630 @default.
• W2807687788 hasConceptScore W2807687788C104317684 @default.
• W2807687788 hasConceptScore W2807687788C147483822 @default.
• W2807687788 hasConceptScore W2807687788C203014093 @default.
• W2807687788 hasConceptScore W2807687788C22070199 @default.
• W2807687788 hasConceptScore W2807687788C2777863537 @default.
• W2807687788 hasConceptScore W2807687788C2778222588 @default.
• W2807687788 hasConceptScore W2807687788C55493867 @default.
• W2807687788 hasConceptScore W2807687788C60987743 @default.
• W2807687788 hasConceptScore W2807687788C86803240 @default.
• W2807687788 hasConceptScore W2807687788C8891405 @default.
• W2807687788 hasConceptScore W2807687788C89423630 @default.
• W2807687788 hasFunder F4320322783 @default.
• W2807687788 hasFunder F4320332161 @default.
• W2807687788 hasFunder F4320337355 @default.
• W2807687788 hasIssue "28" @default.
• W2807687788 hasLocation W28076877881 @default.
• W2807687788 hasLocation W28076877882 @default.

• next